Etravirine and rilpivirine-specific mutations selected by efavirenz and nevirapine exposure in patients infected with HIV-1 non-B subtypes

AIDS. 2014 Sep 24;28(15):2331-2. doi: 10.1097/QAD.0000000000000350.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alkynes
  • Anti-HIV Agents / pharmacology
  • Anti-HIV Agents / therapeutic use*
  • Benzoxazines / therapeutic use*
  • Cyclopropanes
  • Drug Resistance, Viral*
  • Genotype
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Reverse Transcriptase / genetics
  • HIV-1 / classification
  • HIV-1 / enzymology
  • HIV-1 / genetics*
  • HIV-1 / isolation & purification
  • Humans
  • Mutation, Missense*
  • Nevirapine / therapeutic use*
  • Nitriles / pharmacology
  • Pyridazines / pharmacology
  • Pyrimidines / pharmacology
  • Rilpivirine
  • Treatment Outcome
  • Viral Load

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Nitriles
  • Pyridazines
  • Pyrimidines
  • etravirine
  • Nevirapine
  • HIV Reverse Transcriptase
  • Rilpivirine
  • efavirenz